| 000 | 01084nam a2200253 a 4500 | ||
|---|---|---|---|
| 001 | vtls000178991 | ||
| 003 | UG-KaMUL | ||
| 005 | 20250609192252.0 | ||
| 039 | 9 |
_a 201004121142 _b 952 _c 200908031951 _d 964 _c 200907131641 _d 902 _c 200806111811 _d 952 _y 200605311752 _z 951 |
|
| 040 | _a UG-KaMUL | ||
| 082 |
_a 362.1782 _2 22 |
||
| 092 | _a PF 362.1782 H69 | ||
| 245 | 0 | 2 |
_a How health care reform affects pharmaceutical research and developme nt / _c the Congress of the United States, Congressional Budget Office. |
| 246 | 1 | 4 |
_a A CBO Study : _b how health care reform affects pharmaceutical resea rch and development |
| 260 |
_a Washington, D.C. : _b Congressional Budget Office, _c 1994. |
||
| 300 |
_a xv, 64 p. ; _c 28cm. |
||
| 362 | _a June, 1994. | ||
| 650 | 0 |
_a Pharmaceutical industry _z United States. |
|
| 650 | 0 |
_a Drugs _x Research _z United States. |
|
| 650 | 0 |
_a Pharmaceutical services insurance _x Government policy _z United Sta tes. |
|
| 710 | 1 |
_a United States. _b Congressional Budget Office. |
|
| 942 |
_2ddc _cBK |
||
| 999 |
_c331211 _d331211 |
||